Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane vs Propofol for Pituitary Adenoma Resection
NCT05822817Phase 4Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- May 2023
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sevoflurane and propofol injection (veterinary) in pituitary adenoma (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: 15-item Quality of Recovery Score. Started May 2023; status: completed.
02
Drugs
sevofluranepropofol injection (veterinary)
03
Conditions
pituitary adenoma
Beyond the preview
Go deeper on NCT05822817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05822817.